Keyphrases
Gene Expression
100%
Metabolism
100%
Acute Myeloid Leukemia
100%
RNA Expression
100%
Cytarabine
100%
Ara-C
100%
Resistance Index
28%
Sensitive Sample
21%
Treatment Outcome
14%
Leukemia Patients
14%
Low Resistance
14%
Global Gene Expression Profiling
14%
Ribonucleotide Reductase Subunit M1
14%
MTT Assay
14%
Deoxycytidine Kinase
14%
Chemotherapy
7%
Potential Biomarkers
7%
MRNA Expression
7%
Gene Expression Pattern
7%
High Incidence
7%
Cytotoxicity
7%
Highly Sensitive
7%
Acute Myeloid Leukemia Cells
7%
Leukemia Therapy
7%
Drug Response
7%
Treatment Toxicity
7%
IC50 Value
7%
Drug Treatment
7%
Treatment Side Effects
7%
Response-outcome
7%
Differentially Expressed
7%
Apoptotic Pathway
7%
Cytidine Deaminase
7%
Differentially Expressed Genes
7%
Candidate Gene Expression
7%
Daunorubicin
7%
Inter-individual Variation
7%
Background Variation
7%
Equilibrative nucleoside Transporter
7%
Metabolic Pathways Genes
7%
Toxic Side Effects
7%
Induction Mortality
7%
C-responses
7%
Derived Quotient
7%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
100%
RNA
100%
Myeloid
100%
Cytarabine
100%
Gene Expression Profiling
11%
Ribonucleotide Reductase
11%
Gene Expression
11%
Deoxycytidine Kinase
11%
MTT Assay
11%
Candidate Gene
5%
Cytogenetics
5%
High Risk Population
5%
Drug Response
5%
IC50
5%
Daunorubicin
5%
Cytotoxicity
5%
Cytidine Deaminase
5%
Equilibrative Nucleoside Transporter 1
5%
Messenger RNA
5%
Programmed Cell Death
5%
Drug Therapy
5%
Differentially Expressed Gene
5%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Cytarabine
100%
Ex Vivo
35%
Resistance Index
23%
Gene Expression
11%
Gene Expression Profiling
11%
Ribonucleotide Reductase
11%
MTT Assay
11%
Deoxycytidine Kinase
11%
Side Effect
5%
Biological Marker
5%
Leukemia Cell
5%
Drug Therapy
5%
High Risk Population
5%
Programmed Cell Death
5%
Drug Response
5%
Liposomal Daunorubicin
5%
Cytidine Deaminase
5%
Equilibrative Nucleoside Transporter 1
5%
Cytotoxicity
5%
IC50
5%
Messenger RNA
5%